+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Autologous Wound Patches - Global Strategic Business Report

  • PDF Icon

    Report

  • 269 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6070930
Description Jump to:
The global market for Autologous Wound Patches was estimated at US$65.5 Million in 2024 and is projected to reach US$100.9 Million by 2030, growing at a CAGR of 7.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Autologous Wound Patches market.

Global Autologous Wound Patches Market - Key Trends & Drivers Summarized

How Are Autologous Wound Patches Advancing Wound Care?

Autologous wound patches, derived from a patient's own cells or plasma, are transforming wound care by promoting natural healing and reducing the risk of infection. These patches are particularly effective for chronic and hard-to-heal wounds, such as diabetic ulcers and pressure sores. By leveraging the patient's biological materials, autologous patches stimulate tissue regeneration, minimize scarring, and reduce immune rejection risks. With the rising prevalence of chronic wounds, these patches are becoming a critical component of advanced wound management strategies.

What Trends Are Shaping the Autologous Wound Patches Market?

Several trends are driving innovation in the autologous wound patches market. The increasing adoption of personalized medicine has boosted demand for patient-specific treatments like autologous patches. Advances in cell therapy and regenerative medicine are enabling the development of next-generation wound care solutions. The integration of point-of-care systems for patch preparation is improving accessibility and reducing treatment time. Additionally, the focus on reducing healthcare costs is driving interest in technologies that accelerate healing and minimize hospital stays.

How Are Autologous Patches Benefiting Patients and Healthcare Systems?

Autologous wound patches offer significant benefits, including enhanced healing outcomes, reduced infection rates, and minimal side effects. For patients, these patches improve quality of life by reducing pain and promoting faster recovery. Healthcare systems benefit from lower costs associated with shorter treatment durations and reduced hospital readmissions. The use of autologous patches also aligns with the growing emphasis on sustainable and biocompatible solutions in healthcare. These advantages underscore the transformative potential of autologous wound patches in modern medicine.

What Drives the Growth in the Autologous Wound Patches Market?

The growth in the autologous wound patches market is driven by the rising incidence of chronic wounds, advancements in regenerative medicine, and increasing adoption of personalized treatment approaches. Government initiatives supporting innovative wound care solutions are fostering market development. The integration of automated systems for patch preparation is improving scalability and efficiency. Additionally, the growing prevalence of diabetes and aging populations is creating a robust demand for advanced wound care technologies. These factors collectively support the strong growth trajectory of the autologous wound patches market.

Scope of Study:

The report analyzes the Autologous Wound Patches market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Type (Platelet Rich Fibrin, Platelet Rich Plasma); Application (Acute Wounds Application, Chronic Wounds Application); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Surgical Center End-Use)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Platelet Rich Fibrin segment, which is expected to reach US$56.8 Million by 2030 with a CAGR of a 9.1%. The Platelet Rich Plasma segment is also set to grow at 5.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $17.8 Million in 2024, and China, forecasted to grow at an impressive 12.0% CAGR to reach $21.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Autologous Wound Patches Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Autologous Wound Patches Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Autologous Wound Patches Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Arthrex GmbH, B. Braun SE, Integra LifeSciences Corporation, Medtronic PLC, MiMedx Group, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 41 companies featured in this Autologous Wound Patches market report include:

  • Arthrex GmbH
  • B. Braun SE
  • Integra LifeSciences Corporation
  • Medtronic PLC
  • MiMedx Group, Inc.
  • Nuo Therapeutics, Inc. (Aurix)
  • Organogenesis, Inc.
  • PRP Concepts
  • Reapplix A/S
  • RedDress
  • Smith+Nephew
  • Stryker Corporation
  • Terumo Corporation
  • Tissue Regenix Ltd.
  • Zimmer Biomet Holdings, Inc.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Autologous Wound Patches - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Chronic Wounds and Ulcers Drives Market Demand
Increasing Use of Autologous Therapies in Regenerative Medicine
Improved Outcomes in Diabetic and Pressure Ulcer Treatments Fuel Adoption
Technological Advances in Platelet-Rich Plasma and Tissue Engineering
Preference for Minimally Invasive Wound Care Solutions Boosts Growth
Hospitals and Clinics Emphasize Personalized, Patient-Derived Therapies
Expansion of Outpatient and Home-Based Wound Management Services
Growing Geriatric Population Increases Need for Advanced Healing Products
Favorable Clinical Outcomes Support Broader Clinical Acceptance
Surge in Burn Cases and Skin Trauma Drives Demand for Effective Healing
Adoption in Sports Medicine and Orthopedic Applications Expands Market Scope
Rising Use of 3D Printing in Patch Fabrication Enhances Customization
Focus on Reducing Hospital Stay and Surgical Interventions Spurs Demand
Collaborations Between Biotech Firms and Wound Care Clinics Accelerate R&D
Increased Funding for Stem Cell and Platelet-Based Innovations
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Autologous Wound Patches Market Analysis of Annual Sales in US$ for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Autologous Wound Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Autologous Wound Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Platelet Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Platelet Rich Fibrin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Platelet Rich Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Platelet Rich Plasma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Acute Wounds Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Acute Wounds Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Chronic Wounds Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Chronic Wounds Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Ambulatory Surgical Center End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Ambulatory Surgical Center End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 18: USA Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 19: USA 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 20: USA Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 21: USA 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 22: USA Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 23: USA 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
CANADA
TABLE 24: Canada Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 25: Canada 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 26: Canada Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 28: Canada Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 29: Canada 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
JAPAN
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 30: Japan Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 31: Japan 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 32: Japan Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 34: Japan Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 35: Japan 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
CHINA
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 36: China Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 37: China 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 38: China Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 39: China 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 40: China Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 41: China 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
EUROPE
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 42: Europe Recent Past, Current & Future Analysis for Autologous Wound Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 43: Europe 6-Year Perspective for Autologous Wound Patches by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
TABLE 44: Europe Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 45: Europe 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 46: Europe Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 47: Europe 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 48: Europe Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 49: Europe 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
FRANCE
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 50: France Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 51: France 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 52: France Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 53: France 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 54: France Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 55: France 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
GERMANY
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 56: Germany Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 57: Germany 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 58: Germany Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 59: Germany 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 60: Germany Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 61: Germany 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
ITALY
TABLE 62: Italy Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 63: Italy 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 64: Italy Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 65: Italy 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 66: Italy Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 67: Italy 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
UNITED KINGDOM
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 68: UK Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 69: UK 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 70: UK Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 71: UK 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 72: UK Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 73: UK 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
SPAIN
TABLE 74: Spain Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 75: Spain 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 76: Spain Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 77: Spain 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 78: Spain Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 79: Spain 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
RUSSIA
TABLE 80: Russia Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 81: Russia 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 82: Russia Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 83: Russia 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 84: Russia Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 85: Russia 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 87: Rest of Europe 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 89: Rest of Europe 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 91: Rest of Europe 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
ASIA-PACIFIC
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Wound Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 93: Asia-Pacific 6-Year Perspective for Autologous Wound Patches by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Wound Patches by Type - Platelet Rich Fibrin and Platelet Rich Plasma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 95: Asia-Pacific 6-Year Perspective for Autologous Wound Patches by Type - Percentage Breakdown of Value Sales for Platelet Rich Fibrin and Platelet Rich Plasma for the Years 2025 & 2030
TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Wound Patches by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 97: Asia-Pacific 6-Year Perspective for Autologous Wound Patches by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Wound Patches by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific 6-Year Perspective for Autologous Wound Patches by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgical Center End-Use for the Years 2025 & 2030
AUSTRALIA
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Autologous Wound Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Arthrex GmbH
  • B. Braun SE
  • Integra LifeSciences Corporation
  • Medtronic PLC
  • MiMedx Group, Inc.
  • Nuo Therapeutics, Inc. (Aurix)
  • Organogenesis, Inc.
  • PRP Concepts
  • Reapplix A/S
  • RedDress
  • Smith+Nephew
  • Stryker Corporation
  • Terumo Corporation
  • Tissue Regenix Ltd.
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages269
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 65.5 Million
Forecasted Market Value ( USD ) by 2030 $ 100.9 Million
Compound Annual Growth Rate7.5%
Regions CoveredGlobal

Related Topics

Related Reports

Autologous Wound Patches Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Autologous Wound Patches Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Patch Based Wound Healing Products - Global Strategic Business Report - Product Image

Patch Based Wound Healing Products - Global Strategic Business Report

  • Report
  • 269 Pages
  • Global
From
Wound Biologics Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Wound Biologics Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Wound Care Biologics - Global Strategic Business Report - Product Image

Wound Care Biologics - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Wound Healing Biomaterials - Volume 1. Therapies and Regeneration. Woodhead Publishing Series in Biomaterials - Product Image

Wound Healing Biomaterials - Volume 1. Therapies and Regeneration. Woodhead Publishing Series in Biomaterials

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.